Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 20051862 | HLA (HLA) | vasculitides | NA | NA | NA | unclassified | |
| associations of various hla alleles with different vasculitides have been replicated. | |||||||
| 26014903 | HLA-DPB1 (HLA-DPB1) | vasculitides | Chinese | NA | rs3117242 | unclassified | |
| hla-dpb1 variant rs3117242 is associated with anti-neutrophil cytoplasmic antibody-associated vasculitides in a han chinese population. | |||||||
| 26014903 | HLA-DPB1 (HLA-DPB1) | anti-neutrophil cytoplasmic antibody-associated vasculiti | Chinese | NA | rs3117242 | unclassified | |
| hla-dpb1 variant rs3117242 is associated with anti-neutrophil cytoplasmic antibody-associated vasculitides in a han chinese population. | |||||||
| 32889730 | HLA-B*51 | vasculitides | NA | NA | NA | unclassified | |
| the disease frequently has overlapping features resembling other disease clusters, such as vasculitides, spondyloarthritides and thrombophilias with similar genetic risk variants, namely hla-b*51, erap1, il-10, il-23r. | |||||||
| 32889730 | HLA-B*51 | thrombophilias | NA | NA | NA | unclassified | |
| the disease frequently has overlapping features resembling other disease clusters, such as vasculitides, spondyloarthritides and thrombophilias with similar genetic risk variants, namely hla-b*51, erap1, il-10, il-23r. | |||||||
| 20110394 | DP (HAPLOTYPE) | hyperoxia | NA | NA | NA | unclassified | |
| 130 patients with narcolepsy-cataplexy (mean +- sd age 20 +- 10 yrs, 69% male) and 117 controls (22 +- 6.9 yrs, 62% male) were recruited and tested for human leukocyte antigen (hla)-dqb1*0602 status, hyperoxia hypercapnic (change in minute ventilation (dv'(e))/carbon dioxide tension (dp(co(2))) l*min(-1)*mmhg(-1)) and hypoxic (dv'(e) /change in arterial oxygen saturation measured by probe oximetry (ds(p,o(2))) l*min(-1) per %s(p,o(2))) responsiveness, and by spirometry. | |||||||
| 20110394 | HLA-DQB1*06 | hyperoxia | NA | NA | NA | unclassified | |
| 130 patients with narcolepsy-cataplexy (mean +- sd age 20 +- 10 yrs, 69% male) and 117 controls (22 +- 6.9 yrs, 62% male) were recruited and tested for human leukocyte antigen (hla)-dqb1*0602 status, hyperoxia hypercapnic (change in minute ventilation (dv'(e))/carbon dioxide tension (dp(co(2))) l*min(-1)*mmhg(-1)) and hypoxic (dv'(e) /change in arterial oxygen saturation measured by probe oximetry (ds(p,o(2))) l*min(-1) per %s(p,o(2))) responsiveness, and by spirometry. | |||||||
| 20120086 | HLA-G (HLA-G) | organ grafting | NA | NA | NA | unclassified | |
| [hla-g: from feto-maternal tolerance to organ grafting]. | |||||||
| 20140024 | HLA IDENTICAL (HLA-IDENTICAL) | fludarabine | NA | melphalan | NA | negative | |
| NA | |||||||
| 20171113 | HLA-DR (HLA-DR) | wound infections | NA | NA | NA | negation | |
| eight patients developed early wound infections, with no correlation with any of the measured parameters, including magnitude and duration of decrease in hla-dr antigen expression on monocytes. | |||||||
Copyright 2024